Metabolite Card

Formula: C6H9N3O2 (155.0695)
SMILES: N[C@@H](CC1=CN=CN1)C(O)=O

Synonyms [en]

L-histidine; histidine; his; (S)-alpha-Amino-1H-imidazole-4-propionic acid; L-His; (S)-4-(2-Amino-2-carboxyethyl)imidazole

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

L-Histidine. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000013043). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

Histidine (His), also known as L-histidine, is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (–NH2) and carboxyl (–COOH) functional groups, along with a side chain (R group) specific to each amino acid. Histidine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Histidine is found in all organisms ranging from bacteria to plants to animals. It is classified as an aliphatic, positively charged or basic amino acid. Histidine is a unique amino acid with an imidazole functional group. The acid-base properties of the imidazole side chain are relevant to the catalytic mechanism of many enzymes such as proteases. In catalytic triads, the basic nitrogen of histidine abstracts a proton from serine, threonine, or cysteine to activate it as a nucleophile. In a histidine proton shuttle, histidine is used to quickly shuttle protons. It can do this by abstracting a proton with its basic nitrogen to make a positively charged intermediate and then use another molecule to extract the proton from its acidic nitrogen. Histidine forms complexes with many metal ions. The imidazole sidechain of the histidine residue commonly serves as a ligand in metalloproteins. Histidine was first isolated by German physician Albrecht Kossel in 1896. Histidine is an essential amino acid in humans and other mammals. It was initially thought that it was only essential for infants, but longer-term studies established that it is also essential for adults. Infants four to six months old require 33 mg/kg of histidine. It is not clear how adults make small amounts of histidine, and dietary sources probably account for most of the histidine in the body. Histidine is a precursor for histamine and carnosine biosynthesis. Inborn errors of histidine metabolism, including histidinemia, maple syrup urine disease, propionic acidemia, and tyrosinemia I, exist and are marked by increased histidine levels in the blood. Elevated blood histidine is accompanied by a wide range of symptoms, from mental and physical retardation to poor intellectual functioning, emotional instability, tremor, ataxia and psychosis. Histidine and other imidazole compounds have anti-oxidant, anti-inflammatory and anti-secretory properties (PMID: 9605177 ). The efficacy of L-histidine in protecting inflamed tissue is attributed to the capacity of the imidazole ring to scavenge reactive oxygen species (ROS) generated by cells during acute inflammatory response (PMID: 9605177 ). Histidine, when administered in therapeutic quantities is able to inhibit cytokines and growth factors involved in cell and tissue damage (US patent 6150392). Histidine in medical therapies has its most promising trials in rheumatoid arthritis where up to 4.5 g daily have been used effectively in severely affected patients. Arthritis patients have been found to have low serum histidine levels, apparently because of very rapid removal of histidine from their blood (PMID: 1079527 ). Other patients besides arthritis patients that have been found to be low in serum histidine are those with chronic renal failure. Urinary levels of histidine are reduced in pediatric patients with pneumonia (PMID: 2084459 ). Asthma patients exhibit increased serum levels of histidine over normal controls (PMID: 23517038 ). Serum histidine levels are lower and are negatively associated with inflammation and oxidative stress in obese women (PMID: 23361591 ). Histidine supplementation has been shown to reduce insulin resistance, reduce BMI and fat mass and suppress inflammation and oxidative stress in obese women with metabolic syndrome. Histidine appears to suppress pro-inflammatory cytokine expression, possibly via the NF-κB pathway, in adipocytes (PMID: 23361591 ). Low plasma concentrations of histidine are associated with protein-energy wasting, inflammation, oxidative stress, and greater mortality in chronic kidney disease patients (PMID: 18541578 ). Histidine may have many other possible functions because it is the precursor of the ubiquitous neurohormone-neurotransmitter histamine. Histidine increases histamine in the blood and probably in the brain. Low blood histamine with low serum histidine occurs in rheumatoid arthritis patients. Low blood histamine also occurs in some manic, schizophrenic, high copper and hyperactive groups of psychiatric patients. Histidine is a useful therapy in all patients with low histamine levels (http://www.dcnutrition.com).

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 4998-57-6
  • CAS Registry Number: 5934-29-2
  • CAS Registry Number: 71-00-1
  • PubChem: 3435
  • PubChem: 6274
  • PubChem: 6971009
  • PubChem: 773
  • ChEBI: ChEBI:15971
  • ChEBI: ChEBI:27570
  • ChEBI: ChEBI:57595
  • HMDB: HMDB0000177
  • HMDB: HMDB00177
  • KEGG: C00135
  • KEGG: D00032
  • BioCyc: HIS
  • NCBI MeSH: Histidine
  • Wikipedia: Histidine
  • Wikipedia: L-histidine
  • DrugBank: DB00117
  • RefMet: RM0129894
  • MoNA: CCMSLIB00000577965
  • MoNA: CCMSLIB00000578040
  • MoNA: CCMSLIB00000578200
  • MoNA: CCMSLIB00000578286
  • MoNA: EMBL-MCF_spec115068
  • MoNA: EMBL-MCF_spec133653
  • MoNA: EMBL-MCF_spec133724
  • MoNA: EMBL-MCF_spec356968
  • MoNA: EMBL-MCF_spec386215
  • MoNA: EMBL-MCF_spec386217
  • MoNA: EMBL-MCF_spec386229
  • MoNA: EMBL-MCF_spec387514
  • MoNA: EMBL-MCF_spec387526
  • MoNA: EMBL-MCF_spec387527
  • MoNA: EMBL-MCF_spec43810
  • MoNA: EMBL-MCF_spec63504
  • MoNA: HMDB0000177_c_ms_1646
  • MoNA: HMDB0000177_c_ms_1833
  • MoNA: HMDB0000177_ms_ms_283
  • MoNA: HMDB0000177_ms_ms_284
  • MoNA: HMDB0000177_ms_ms_285
  • MoNA: KNA00085
  • MoNA: KNA00356
  • MoNA: KNA00499
  • MoNA: KNA00500
  • MoNA: KNA00740
  • MoNA: KNA00741
  • MoNA: KO000958
  • MoNA: KO000959
  • MoNA: KO000960
  • MoNA: KO000961
  • MoNA: KO000962
  • MoNA: KO003054
  • MoNA: KO003055
  • MoNA: KO003056
  • MoNA: KO003057
  • MoNA: KO003058
  • MoNA: KZ000045
  • MoNA: KZ000155
  • MoNA: MoNA003305
  • MoNA: MoNA003306
  • MoNA: MoNA003307
  • MoNA: MoNA003308
  • MoNA: MoNA003309
  • MoNA: MoNA003310
  • MoNA: MoNA010113
  • MoNA: MoNA010114
  • MoNA: MoNA010115
  • MoNA: MoNA010116
  • MoNA: MoNA010117
  • MoNA: MoNA010118
  • MoNA: MT000022
  • MoNA: OUF00309
  • MoNA: OUF01016
  • MoNA: PB000422
  • MoNA: PB000423
  • MoNA: PB000424
  • MoNA: PB000425
  • MoNA: PM000935
  • MoNA: PR010033
  • MoNA: PR030009
  • MoNA: PR100027
  • MoNA: PR100028
  • MoNA: PR100321
  • MoNA: PR100495
  • MoNA: PR100755
  • MoNA: PS005101
  • MoNA: PS005102
  • MoNA: PS005103
  • MoNA: PS005107
  • MoNA: PS071801
  • MoNA: PS071802
  • MoNA: PS071803
  • MoNA: PS071807
  • MoNA: PT100510
  • MoNA: PT100513
  • MoNA: PT107180
  • MoNA: PT200510
  • MoNA: PT207180
  • MoNA: RP002001
  • MoNA: RP002002
  • MoNA: RP002003
  • MoNA: RP002011
  • MoNA: RP002012
  • MoNA: RP002013
  • Metlin: METLIN_21

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R01158 1.1.1.23 L-histidinol:NAD+ oxidoreductase
KEGG:R01159 2.1.1.- S-adenosyl-L-methionine:L-histidine N-methyltransferase
KEGG:R01160 2.3.1.33 acetyl-CoA:L-histidine N-acetyltransferase
KEGG:R01161 2.6.1.38 L-histidine:2-oxoglutarate aminotransferase
KEGG:R01163 1.1.1.23 L-histidinal:NAD+ oxidoreductase
KEGG:R01164 6.3.2.11 L-histidine:beta-alanine ligase (ADP-forming)
KEGG:R01166 3.4.13.18 Nalpha-(beta-alanyl)-L-histidine hydrolase
KEGG:R01167 4.1.1.22 L-histidine carboxy-lyase (histamine-forming)
KEGG:R01168 4.3.1.3 L-histidine ammonia-lyase (urocanate-forming)
KEGG:R01169 2.1.1.44 S-adenosyl-L-methionine:L-histidine Nalpha-methyltransferase
KEGG:R01991 6.3.2.11 L-histidine:4-aminobutanoate ligase (ADP-forming)
KEGG:R01992 3.4.13.18 alpha-aminobutyryl histidine hydrolase
KEGG:R03655 6.1.1.21 L-histidine:tRNA(His) ligase (AMP-forming)
KEGG:R08412 C00135 + C08262<=>C16696
KEGG:R08413 C00135<=>C07474
KEGG:R10523 2.1.1.44 S-adenosyl-L-methionine:L-histidine Nalpha-methyltransferase
KEGG:R10686 C00018 + C00135<=>C04556
KEGG:R11015 1.14.99.52 L-histidine,L-cysteine:oxygen [S-(L-histidin-5-yl)-L-cysteine S-oxide-forming]
KEGG:R12313 5.1.1.24 histidine racemase
KEGG:R12436 6.3.2.- C00078 + C00135<=>C22162
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
BioCyc:TRYPANO_PRPP-PWY superpathway of histidine, purine, and pyrimidine biosynthesis
BioCyc:LEISH_TRNA-CHARGING-PWY tRNA charging pathway
BioCyc:TRYPANO_PWY1V8-6774 ovothiol biosynthesis
BioCyc:LEISH_PWY3IU-325 ovothiol A biosynthesis
BioCyc:TRYPANO_HISTSYN-PWY histidine biosynthesis
PathBank:SMP0000820 tRNA Charging
PathBank:SMP0000824 tRNA Charging 2
PathBank:SMP0000830 Histidine Biosynthesis
PathBank:SMP0001000 Secondary Metabolites: Histidine Biosynthesis
WikiPathways:WP522 Biogenic amine synthesis
WikiPathways:WP3604 Biochemical pathways: part I
WikiPathways:WP4661 Amino acid metabolism pathway excerpt: histidine catabolism extension
WikiPathways:WP3622 AtMetExpress overview
WikiPathways:WP1581 Histidine metabolism
WikiPathways:WP662 Amino acid metabolism
WikiPathways:WP661 Glucose homeostasis
WikiPathways:WP125 Biogenic amine synthesis
WikiPathways:WP5313 Carnosine metabolism of glial cells
WikiPathways:WP3925 Amino acid metabolism
PathBank:SMP0120698 GABA-Transaminase Deficiency
View All Pathways